| __timestamp | Bausch Health Companies Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 11606000000 |
| Thursday, January 1, 2015 | 2682700000 | 10313000000 |
| Friday, January 1, 2016 | 2810000000 | 9762000000 |
| Sunday, January 1, 2017 | 2582000000 | 9830000000 |
| Monday, January 1, 2018 | 2473000000 | 10102000000 |
| Tuesday, January 1, 2019 | 2554000000 | 10615000000 |
| Wednesday, January 1, 2020 | 2367000000 | 8955000000 |
| Friday, January 1, 2021 | 2624000000 | 9634000000 |
| Saturday, January 1, 2022 | 2625000000 | 10042000000 |
| Sunday, January 1, 2023 | 2917000000 | 10504000000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Merck & Co., Inc. and Bausch Health Companies Inc. have demonstrated contrasting strategies in optimizing these costs. From 2014 to 2023, Merck's SG&A expenses have shown a slight decline, with a notable reduction of approximately 10% from 2014 to 2020. In contrast, Bausch Health's expenses have fluctuated, peaking in 2023 with a 44% increase from 2014. This divergence highlights Merck's consistent cost management approach, while Bausch Health's strategy appears more variable. As the industry evolves, these trends offer valuable insights into how major players navigate financial efficiency, impacting their competitive edge and market positioning.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Bristol-Myers Squibb Company
Merck & Co., Inc. vs BeiGene, Ltd.: SG&A Expense Trends
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Bausch Health Companies Inc.
Breaking Down SG&A Expenses: Merck & Co., Inc. vs MorphoSys AG
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Vericel Corporation
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Galapagos NV
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Taro Pharmaceutical Industries Ltd.
GSK plc and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? argenx SE or Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Catalyst Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Geron Corporation